29th Annual Meeting of the American Society of Photobiology

Downtown Marriot

Chicago, Il.

July 7th-12th, 2001


Towards the Jablonski Diagram for PDT In Vivo

Wilson, Brian1
Ontario Cancer Institute/University of Toronto, Canada1

Abstract-
The photophysical processes in photodynamic therapy (PDT) for most photosensitizers used clinically are: photon absorption from the ground state (So) to the first excited state (S1), intersystem crossing to the triplet state (T1) and energy/spin exchange with ground state molecular oxygen (3O2) to produce cytotoxic singlet state oxygen (1O2). While these steps, described by the Jablonski diagram, are relatively straightforward to measure in solution, there are significant theoretical and technological problems in their determination in tissue in vivo, or even in cells in vitro. In this presentation the status of techniques and corresponding models for measuring each state will be critically examined. Thus, for example, either diffuse reflectance spectroscopy or fluorescence spectroscopy may be used to determine the ground-state concentration of photosensitizer, given knowledge of the excitation light distribution. The triplet state may be investigated using transient absorption spectroscopy, in a pump-probe configuration, and its decay kinetics may yield the ground-state oxygen concentration. As we have recently demonstrated, the singlet oxygen may be measured by near-infrared luminescence decay. A major challenge in all of these techniques is to make absolute measurements of the state concentrations, given the confounding factors of high light scattering and endogenous absorption of tissues. Approaches explored include both spatially- and temporally-resolved spectroscopies. Individual techniques raise specific additional issues, such as low signal levels due to low transient concentrations (T1 and 1O2) that push the current technological envelop. Barriers to successful implementation, both in the laboratory and in the clinic will be considered. Speculation on future complicating factors will include photosensitizers that have alternative or additional excitation pathways and 2-photon PDT. The discussion will conclude by considering how much of the Jablonski diagram one needs to determine in order to be useful for improving PDT treatments.

Keywords: photodynamic, Jablonski